01 4AUROBINDO PHARMA ITALIA Srl
02 4Accord Healthcare AG
03 4Accord Healthcare Ltd.
04 5Actavis Group hf.
05 4AqVida GmbH
06 1BLUEPHARMA - INDUSTRIA FARMACEUTICA, S.A
07 1BMM Pharma AB
08 1Baxalta Innovations GmbH
09 1EBEWE Pharma Ges.mbHNfg.KG
10 8FRESENIUS KABI ONCOLOGY PLC
11 4Fresenius Kabi (Switzerland) AG
12 2Fresenius Kabi Oncology Plc
13 1GP PHARM
14 3HOSPIRA ITALIA Srl
15 4Hospira UK Limited
16 3Labatec Pharma SA
17 3MYLAN SpA
18 1Martindale Pharmaceuticals Ltd.
19 1Mylan AB
20 1Mylan Hospital AS
21 3PFIZER LTD (SANDWICH UK)
22 3Pfizer AG
23 1Regio Medica GmbH
24 3SANDOZ GMBH
25 4SEACROSS PHARMACEUTICALS
26 1STADA Arzneimittel AG
27 1Sandoz A / S,
28 4Sandoz Pharmaceuticals AG
29 1Seacross Pharmaceuticals Limited,
30 1Sun Pharmaceutical Industries
31 4Teva Pharma AG
32 1Teva Sweden AB
33 8The Fresenius Kabi Oncology Plc
34 1medac Gesellschaft für
35 1ratiopharm GmbH
01 53Irinotecan
02 22Irinotecani Hydrochloridum Trihydricum
03 18irinotecan
01 18CONCENTRATE FOR SOLUTION FOR INFUSION
02 8Concentrate to the infusion fluid
03 12Concentrate to the infusion fluid, resolution
04 18Inf Conc
05 1Inf Conc.
06 3Inf Konz
07 7Irinotecan 100Mg 5Ml 1 Units Parenteral Use
08 5Irinotecan 300Mg 15Ml 1 Units Parenteral Use
09 6Irinotecan 40Mg 2Ml 1 Units Parenteral Use
10 1Irinotecan 40Mg 2Ml 5 Units Parenteral Use
11 5Irinotecan 500Mg 25Ml 1 Units Parenteral Use
12 1Liposome Injection
13 4SOLUTION
14 4SOLUTION FOR INFUSION
01 4Germany
02 24Italy
03 20Norway
04 1Portugal
05 18Sweden
06 22Switzerland
07 4United Kingdom
01 6Campto
02 5Irinokabi
03 1Irinosor
04 18Irinotecan
05 8Irinotecan Accord
06 4Irinotecan Actavis
07 1Irinotecan CSC
08 1Irinotecan Ebewe
09 4Irinotecan Fresenius
10 3Irinotecan Hospira
11 5Irinotecan Kabi
12 3Irinotecan Labatec
13 1Irinotecan Martindale Pharma
14 2Irinotecan Mylan
15 1Irinotecan Regio Medica
16 1Irinotecan STADA
17 1Irinotecan SUN
18 1Irinotecan Sandoz
19 4Irinotecan Sandoz eco
20 1Irinotecan Seacross
21 1Irinotecan Teva
22 4Irinotecan The Fresenius Kabi
23 1Irinotecan hydrochloride
24 1Irinotecan medac
25 4Irinotecan-Teva liquid
26 1Onivyde
27 1irinotecan
28 9Blank
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Brand Name :
Dosage Form : SOLUTION FOR INFUSION
Dosage Strength : 40MG/2ML
Packaging : Vial (Box)
Approval Date :
Application Number : 90726
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Brand Name :
Dosage Form : SOLUTION FOR INFUSION
Dosage Strength : 100MG/5ML
Packaging : Vial (Box)
Approval Date :
Application Number : 90726
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Brand Name :
Dosage Form : SOLUTION FOR INFUSION
Dosage Strength : 300MG/15ML
Packaging : Vial (Box)
Approval Date :
Application Number : 20571
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Brand Name :
Dosage Form : SOLUTION FOR INFUSION
Dosage Strength : 500MG/25ML
Packaging : Vial (Box)
Approval Date :
Application Number : 78796
Regulatory Info : Generic MA Granted (EU) & Available
Registration Country : Germany
Regulatory Info :
Registration Country : Sweden
Brand Name : Irinokabi
Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION
Dosage Strength : 20 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info : Generic
Registration Country : United Kingdom
Brand Name :
Dosage Form : SOLUTION
Dosage Strength : 40MG/2ML
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : United Kingdom
Regulatory Info : Generic
Registration Country : United Kingdom
Brand Name :
Dosage Form : SOLUTION
Dosage Strength : 100MG/5ML
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : United Kingdom
Regulatory Info : Generic
Registration Country : United Kingdom
Brand Name :
Dosage Form : SOLUTION
Dosage Strength : 300MG/15ML
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : United Kingdom
Regulatory Info : Generic
Registration Country : United Kingdom
Brand Name :
Dosage Form : SOLUTION
Dosage Strength : 500MG/25ML
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : United Kingdom
Regulatory Info :
Registration Country : Sweden
Brand Name : Irinotecan Teva
Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION
Dosage Strength : 20 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
